,for, Item ID- #226416 Providers like you icon 79 American Regent #00517003225 Cyanocobalamin 1,000 mcg / mL Injection 10 mL CYANOCOBALAMIN B12 1000MCG/ML10ML MDV (25/PK) Features Cyanocobalamin Injection, USP is a sterile solution of cyanocobalamin for intramuscular or subcutaneous injection Preserved with 1.5% Benzyl Alcohol Store at controlled room temperature of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit) More Volume 1 mL 10 mL Log in for pricing and availability Log In to Order or Product Specifications Features Cyanocobalamin Injection, USP is a sterile solution of cyanocobalamin for intramuscular or subcutaneous injection Preserved with 1.5% Benzyl Alcohol Store at controlled room temperature of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit) More Information Frequently Viewed Together ,for, Item ID- #1084660 Amneal Pharmaceuticals LLC #70121116901 ,for, Item ID- #226417 American Regent #00517013001 ,for, Item ID- #462548 American Regent #00517003125 ,for, Item ID- #239936 Pfizer #00409427602 ,for, Item ID- #1120326 Amneal Pharmaceuticals LLC #70121104902 ,for, Item ID- #300448 Pfizer #00409427702 ,for, Item ID- #1246630 Piramal Critical Care #66794022841 ,for, Item ID- #993648 Mylan Pharmaceuticals #67457042010 ,for, Item ID- #1222449 International Medication Systems #76329331801 ,for, Item ID- #462517 Fresenius USA #63323020110 ,for, Item ID- #1227965 Meitheal Pharmaceuticals #71288020185 ,for, Item ID- #1208842 BPI Labs #54288012001 ,for, Item ID- #1159863 Somerset Therapeutics LLC #70069002510 ,for, Item ID- #1230114 Long Grove Pharmaceuticals LLC #81298578303 ,for, Item ID- #1200636 Xiromed LLC #70700017223 ,for, Item ID- #501703 Fresenius USA #63323042410
This mechanism increases intracellular concentrations of both NAD+ and SAM, two fundamental molecules that regulate cellular energy expenditure, mitochondrial function, and epigenetic modifications
McElya at Neighborhood Medical Center in Dallas can help you assess your needs and decide the best option for you
With the approval of Rivfloza, we now have a novel treatment that lowers oxalate production safely and effectively. Oct 2: Eli Lilly will have to wait a little longer to see a payoff from lebrikizumab, which it picked up in its $1.1 billion acquisition of Dermira in January 2020
